The store will not work correctly when cookies are disabled.
1-hydroxy-2-(4-dimethylaminopyridinium-1-yl)-ethylidene-1,1-biphosphonic acid
ID: ALA202390
PubChem CID: 11508127
Max Phase: Preclinical
Molecular Formula: C9H17N2O7P2+
Molecular Weight: 327.19
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1cc[n+](CC(O)(P(=O)(O)O)P(=O)(O)O)cc1
Standard InChI: InChI=1S/C9H16N2O7P2/c1-10(2)8-3-5-11(6-4-8)7-9(12,19(13,14)15)20(16,17)18/h3-6,12H,7H2,1-2H3,(H3-,13,14,15,16,17,18)/p+1
Standard InChI Key: PDJZXGLGJUXHQW-UHFFFAOYSA-O
Molfile:
RDKit 2D
20 20 0 0 0 0 0 0 0 0999 V2000
13.8094 -3.7089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5243 -4.1180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2352 -4.5264 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9341 -3.4034 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
14.1180 -4.8346 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
15.3392 -2.6876 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6499 -3.8112 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2190 -2.9947 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7000 -5.5458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8314 -5.2464 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.4051 -4.4217 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0094 -3.9190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.4286 -3.3286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6292 -3.5382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4106 -4.3369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9976 -4.9258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7947 -4.7130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6142 -4.5473 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0338 -3.9628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3982 -5.3423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
5 11 1 0
4 6 2 0
1 12 1 0
1 2 1 0
12 13 2 0
4 7 1 0
13 14 1 0
2 4 1 0
14 15 2 0
4 8 1 0
15 16 1 0
16 17 2 0
17 12 1 0
5 9 2 0
15 18 1 0
2 5 1 0
18 19 1 0
5 10 1 0
18 20 1 0
M CHG 1 12 1
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 327.19 | Molecular Weight (Monoisotopic): 327.0506 | AlogP: -0.96 | #Rotatable Bonds: 5 |
Polar Surface Area: 142.41 | Molecular Species: ACID | HBA: 4 | HBD: 5 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 0.60 | CX Basic pKa: ┄ | CX LogP: -5.62 | CX LogD: -9.41 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.34 | Np Likeness Score: -0.08 |
References
1. Hudock MP, Sanz-Rodríguez CE, Song Y, Chan JM, Zhang Y, Odeh S, Kosztowski T, Leon-Rossell A, Concepción JL, Yardley V, Croft SL, Urbina JA, Oldfield E.. (2006) Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates., 49 (1): [PMID:16392806] [10.1021/jm0582625] |